MarketLens
Sign Up

What Does the Angelini Pharma Acquisition Mean for Catalyst Pharmaceuticals (CPRX) Shareholders

4 months ago
SHARE THIS ON:

What Does the Angelini Pharma Acquisition Mean for Catalyst Pharmaceuticals (CPRX) Shareholders

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 weeks ago

IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?

LB Pharmaceuticals shares have more than tripled since its IPO in under a year, as investors track its neuropsychiatric disorder programs. The rally could attract takeover interest if clinical data re...
Stock News•2 months ago

Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger

Catalyst Pharmaceuticals (CPRX) stockholders approved the merger with Angelini Pharma S.p.A. at a virtual special meeting on July 8, clearing a key regulatory hurdle.
Stock News•2 months ago

CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Crinetics Pharmaceuticals (CRNX) is under investigation by Halper Sadeh LLC over its $85/share cash sale to Vertex, focusing on whether shareholders are receiving fair value.

Breaking News

View All →

Top Headlines

View More →
Stock News•47 minutes ago

New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial

Stock News•1 hour ago

Pilots of crashed Amazon cargo plane were unaware of wind conditions

Stock News•1 hour ago

Alphabet (GOOGL) Stock Sinks As Market Gains: What You Should Know

Stock News•1 hour ago

Micron Isn't Stepping Off The Gas

Stock News•2 hours ago

Buy Micron Stock After AI Memory Demand Fuels Record Q4 Results?